{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:04:13Z","timestamp":1784988253542,"version":"3.55.0"},"reference-count":161,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Psychedelic Medicine"],"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The renewed clinical interest in psychedelics is often framed in ways that blur the distinction between psychotherapy and the psychedelic drug experience itself. Revisiting early research and clinical observations from the first wave of psychedelic science may help clarify how these processes were originally conceptualized. In the mid-20th century, LSD and other serotonergic psychedelics were understood as facilitators of psychotherapy rather than stand-alone treatments. Psycholytic therapy emphasized gradual therapeutic exploration over multiple sessions, whereas psychedelic therapy emphasized discrete, potentially transformative experiences. In both approaches, psychedelic administration was embedded within established psychotherapeutic frameworks, underscoring the importance of the therapeutic alliance, as well as set and setting. Re-examining this history helps reassert psychotherapy as the primary therapeutic mechanism, with psychedelics functioning as catalysts that enhance emotional access, meaning-making, and the therapeutic relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This historical review synthesizes research on psycholytic therapy conducted between 1950 and 1970. It provides an overview of treatment protocols, procedures, and reported outcomes. It also translates therapeutic concepts from the historical literature into contemporary psychological constructs that can be operationalized and examined using modern research methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The historical literature on psycholytic therapy represents a substantial and underutilized clinical resource. Renewed investigation using contemporary clinical trial designs may help clarify its therapeutic potential and inform the development of evidence-based psychedelic-assisted psychotherapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/28314425261455416","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:25:16Z","timestamp":1784708716000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["What About Psycholytic Therapy? A Historical Revisiting of Psychedelics Assisting Psychotherapy"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4665-4730","authenticated-orcid":false,"given":"Idir","family":"Zaher","sequence":"first","affiliation":[{"name":"School of Psychology, Faculty of Social Sciences, University of Ottawa, Ottawa, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-1353","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie K.","family":"Richard","sequence":"additional","affiliation":[{"name":"School of Psychology, Faculty of Social Sciences, University of Ottawa, Ottawa, Ontario, Canada."},{"name":"Department of Psychiatry &amp; Behavioral Sciences, Center for Psychedelic &amp; Consciousness Research, Johns Hopkins School of Medicine, Baltimore, Maryland, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050324515578080"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1684\/ipe.2021.2343"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amp.2022.11.002"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1131565"},{"key":"e_1_3_3_6_1","first-page":"519","volume-title":"Contemp Drug Probl","author":"Bliss K","year":"1988","unstructured":"5.Bliss K. Contemp Drug Probl 1988;15(4):519\u2013563. LSD and psychotherapy."},{"key":"e_1_3_3_7_1","first-page":"154","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Grof S","year":"1967","unstructured":"6.Grof S. The use of LSD-25 in personality diagnostics and therapy of psychogenic disorders. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 154\u2013190."},{"key":"e_1_3_3_8_1","volume-title":"LSD psychotherapy: an exploration of psychedelic and psycholytic therapy","author":"Caldwell WV","year":"1968","unstructured":"7.Caldwell WV. LSD psychotherapy: an exploration of psychedelic and psycholytic therapy. Grove Press: New York, NY; 1968."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1960.03590090042008"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1959.02340170081008"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.109.458.46"},{"key":"e_1_3_3_12_1","first-page":"27","volume-title":"Lysergic acid diethylamide and mescaline in experimental psychiatry","author":"Sandison RA","year":"1956","unstructured":"11.Sandison RA. The clinical uses of LSD. In: Lysergic acid diethylamide and mescaline in experimental psychiatry. (Cholden L., ed.) Grune & Stratton: New York, NY; 1956; pp. 27\u201334."},{"key":"e_1_3_3_13_1","first-page":"441","article-title":"Psycholytic therapy: Statistics and indications","author":"Mascher E","year":"1967","unstructured":"12.Mascher E. Psycholytic therapy: Statistics and indications. Neuropsychopharmacology 1967:441\u2013444.","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_3_14_1","first-page":"50","article-title":"Treatment of the neurotic patient, resistant to the usual techniques of psychotherapy, with special reference to LSD","volume":"4","author":"Arendsen-Hein GW","year":"1963","unstructured":"13.Arendsen-Hein GW. Treatment of the neurotic patient, resistant to the usual techniques of psychotherapy, with special reference to LSD. Top Probl Psychother 1963;4:50\u201357.","journal-title":"Top Probl Psychother"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195812000-00006"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000285664"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/002076405700300304"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1956.9713025"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/002076406701300205"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1037\/10546-020"},{"key":"e_1_3_3_21_1","first-page":"143","volume-title":"Psychedelic reflections","author":"Bastiaans J","year":"1983","unstructured":"20.Bastiaans J. Mental liberation facilitated by the use of hallucinogenic drugs. In: Psychedelic reflections. (Grinspoon L, , Bakalar JB., eds.) Human Sciences Press: New York, NY; 1983; pp. 143\u2013152."},{"key":"e_1_3_3_22_1","first-page":"241","volume-title":"The use of LSD in psychotherapy","author":"Abramson HA","year":"1960","unstructured":"21.Abramson HA. Resolution of counter-identification conflict of father during oedipal phase of son. In: The use of LSD in psychotherapy. (Abramson HA., ed.) Josiah Macy Foundation: New York, NY; 1960; pp. 241\u2013294."},{"key":"e_1_3_3_23_1","first-page":"191","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Baker EFW","year":"1967","unstructured":"22.Baker EFW. LSD psychotherapy; LSD psycho-exploration: three reports. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: New York, NY; 1967; pp. 191\u2013207."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674376100600407"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1963.9916633"},{"issue":"1","key":"e_1_3_3_26_1","first-page":"15","article-title":"Theoretical and empirical basis of transpersonal psychology and psychotherapy: Observations from LSD research","volume":"5","author":"Grof S","year":"1973","unstructured":"25.Grof S. Theoretical and empirical basis of transpersonal psychology and psychotherapy: Observations from LSD research. J Transpers Psychol 1973;5(1):15\u201353.","journal-title":"J Transpers Psychol"},{"key":"e_1_3_3_27_1","first-page":"45","article-title":"Varieties of transpersonal experiences: Observations from LSD psychotherapy","volume":"4","author":"Grof S","year":"1972","unstructured":"26.Grof S. Varieties of transpersonal experiences: Observations from LSD psychotherapy. J Transpers Psychol 1972;4:45\u201380.","journal-title":"J Transpers Psychol"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/anoc.12161"},{"key":"e_1_3_3_29_1","volume-title":"Psycholytic and psychedelic therapy research 1931\u20131995: A complete international bibliography","author":"Passie T","year":"1997","unstructured":"28.Passie T. Psycholytic and psychedelic therapy research 1931\u20131995: A complete international bibliography. Laurentius Publishers: L\u00f6rrach, Germany; 1997."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503245231221154"},{"key":"e_1_3_3_31_1","volume-title":"LSD: my problem child","author":"Hofmann A","year":"1980","unstructured":"30.Hofmann A. LSD: my problem child. McGraw-Hill: New York, NY; 1980."},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.186.6.457"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.84"},{"key":"e_1_3_3_34_1","volume-title":"Convention on psychotropic substances","author":"United Nations","year":"1971","unstructured":"33.United Nations. Convention on psychotropic substances. United Nations: New York, NY; 1971. Available from: United Nations Office on Drugs and Crime."},{"key":"e_1_3_3_35_1","first-page":"177","volume-title":"Psychedelic reflections","author":"Leuner H","year":"1983","unstructured":"34.Leuner H. Psycholytic therapy: hallucinogens as an aid in psychodynamically oriented psychotherapy. In: Psychedelic reflections. (Grinspoon L, , Bakalar JB., eds.) Human Sciences Press: New York, NY; 1983; pp. 177\u2013192."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2025.105525"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1020505"},{"key":"e_1_3_3_38_1","first-page":"101","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Arendsen-Hein GW","year":"1963","unstructured":"37.Arendsen-Hein GW. LSD in the treatment of criminal psychopaths. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 101\u2013106."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01586152"},{"key":"e_1_3_3_40_1","first-page":"542","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Eisner BG","year":"1967","unstructured":"39.Eisner BG. The importance of the non-verbal. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 542\u2013560."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1968.tb01990.x"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1964.tb04949.x"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1964.tb04950.x"},{"key":"e_1_3_3_44_1","first-page":"67","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Leuner H","year":"1963","unstructured":"43.Leuner H. Psychotherapy with hallucinogens: a clinical report with special reference to the revival of emotional phases of childhood. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 67\u201373."},{"key":"e_1_3_3_45_1","first-page":"101","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Leuner H","year":"1967","unstructured":"44.Leuner H. Present state of psycholytic therapy and its possibilities. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 101\u2013116."},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674376601100410"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.100.419.491"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197312000-00002"},{"key":"e_1_3_3_49_1","first-page":"61","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Spencer AM","year":"1963","unstructured":"48.Spencer AM. Permissive group therapy with LSD. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 61\u201366."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1964.tb133752.x"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01532556"},{"key":"e_1_3_3_52_1","first-page":"107","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Cameron K","year":"1963","unstructured":"51.Cameron K. Some experiences with LSD in the treatment of adolescent boys. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 107\u2013111."},{"issue":"8","key":"e_1_3_3_53_1","first-page":"511","article-title":"Lysergide in the treatment of neurosis: A report of two cases","volume":"27","author":"Denson R","year":"1966","unstructured":"52.Denson R. Lysergide in the treatment of neurosis: A report of two cases. Dis Nerv Syst 1966;27(8):511\u2013514.","journal-title":"Dis Nerv Syst"},{"key":"e_1_3_3_54_1","first-page":"125","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Fordham M","year":"1963","unstructured":"53.Fordham M. Analytic observations on patients using hallucinogenic drugs. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 125\u2013130."},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.120.4.396"},{"key":"e_1_3_3_56_1","first-page":"129","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Ling TM","year":"1967","unstructured":"55.Ling TM. The use of LSD-25 and Ritalin in the treatment of neurosis. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 129\u2013153."},{"key":"e_1_3_3_57_1","first-page":"1116","volume-title":"Neuro-psycho-pharmacology","author":"Vourlekis A","year":"1967","unstructured":"56.Vourlekis A, , Faillace LA, , Szara S. Psychotherapy combined with psychodysleptic tryptamine derivatives and an active placebo. In: Neuro-psycho-pharmacology. (Brill H., ed.) Excerpta Medica: Amsterdam; 1967; pp. 1116\u20131118."},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750360047006"},{"issue":"23","key":"e_1_3_3_59_1","first-page":"1200","article-title":"The use of lysergic acid diethylamide (LSD) in psychotherapy","volume":"91","author":"Baker EFW","year":"1964","unstructured":"58.Baker EFW. The use of lysergic acid diethylamide (LSD) in psychotherapy. Can Med Assoc J 1964;91(23):1200\u20131202.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1485-1_2"},{"key":"e_1_3_3_61_1","volume-title":"Lysergic acid (LSD-25) and Ritalin in the treatment of neurosis","author":"Ling TM","year":"1963","unstructured":"60.Ling TM, , Buckman J. Lysergic acid (LSD-25) and Ritalin in the treatment of neurosis. Lambarde Press: London; 1963."},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","unstructured":"61.Yensen R. The use of 3 4-methylenedioxyamphetamine (MDA) as an adjunct to brief intensive psychotherapy with neurotic outpatients. Dissertation. University of California: Berkeley CA; 1975.","DOI":"10.1097\/00005053-197610000-00002"},{"key":"e_1_3_3_63_1","first-page":"208","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"van Rhijn CH","year":"1967","unstructured":"62.van Rhijn CH. Variables in psycholytic treatment. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 208\u2013222."},{"key":"e_1_3_3_64_1","first-page":"64","article-title":"Effects of LSD-25 on psychotherapeutic communication","volume":"10","author":"Dahlberg CC","year":"1964","unstructured":"63.Dahlberg CC. Effects of LSD-25 on psychotherapeutic communication. Psychopharmacol Bull 1964;10:64\u201365.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_65_1","first-page":"1531","article-title":"The nursing and care of mentally ill patients under d-lysergic acid diethylamide","volume":"100","author":"Ball ER","year":"1955","unstructured":"64.Ball ER. The nursing and care of mentally ill patients under d-lysergic acid diethylamide. Nurs Mirror 1955;100:1531\u20131532.","journal-title":"Nurs Mirror"},{"key":"e_1_3_3_66_1","first-page":"141","volume-title":"Psychedelic medicine","author":"Greer GR","year":"2007","unstructured":"65.Greer GR, , Tolbert R. The therapeutic use of MDMA. In: Psychedelic medicine. (Winkelman MJ, , Roberts TB., eds.) Praeger Publishers: Westport, CT; 2007; pp. 141\u2013153."},{"key":"e_1_3_3_67_1","first-page":"237","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Dahlberg CC","year":"1967","unstructured":"66.Dahlberg CC. LSD facilitation of psychoanalytic treatment: a case study in depth. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 237\u2013258."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01573385"},{"key":"e_1_3_3_69_1","first-page":"117","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Langner FW","year":"1967","unstructured":"68.Langner FW. Six years\u2019 experience with LSD therapy. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 117\u2013128."},{"key":"e_1_3_3_70_1","first-page":"394","article-title":"The treatment of twelve male homosexuals with LSD","volume":"10","author":"Martin JA","year":"1962","unstructured":"69.Martin JA. The treatment of twelve male homosexuals with LSD. Acta Psychother Psychosom 1962;10:394\u2013402.","journal-title":"Acta Psychother Psychosom"},{"issue":"2","key":"e_1_3_3_71_1","first-page":"80","article-title":"Supporting the patient on LSD day","volume":"64","author":"Parley K","year":"1964","unstructured":"70.Parley K. Supporting the patient on LSD day. Am J Nurs 1964;64(2):80\u201382.","journal-title":"Am J Nurs"},{"key":"e_1_3_3_72_1","first-page":"25","volume-title":"The use of LSD in psychotherapy","author":"Abramson HA","year":"1960","unstructured":"71.Abramson HA. Psychoanalytic psychotherapy with LSD. In: The use of LSD in psychotherapy. (Abramson HA., ed.) Josiah Macy Foundation: New York, NY; 1960; pp. 25\u201380."},{"key":"e_1_3_3_73_1","volume-title":"LSD psychotherapy","author":"Grof S","year":"1979","unstructured":"72.Grof S. LSD psychotherapy. Hunter House: Pomona, CA; 1979."},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-440X(68)80080-X"},{"issue":"4","key":"e_1_3_3_75_1","first-page":"505","article-title":"The role of psychotropic drugs in group therapy","volume":"21","author":"Sandison RA","year":"1959","unstructured":"74.Sandison RA. The role of psychotropic drugs in group therapy. Bull World Health Organ 1959;21(4\u20135):505\u2013515.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"e_1_3_3_76_1","first-page":"495","article-title":"The role of psychotropic drugs in individual therapy","volume":"21","author":"Sandison RA","year":"1959","unstructured":"75.Sandison RA. The role of psychotropic drugs in individual therapy. Bull World Health Organ 1959;21(4\u20135):495\u2013503.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_77_1","first-page":"308","article-title":"Psychodynamics of LSD hallucinations and their bearing on individual psychotherapy","volume":"7","author":"Hausner M","year":"1963","unstructured":"76.Hausner M, , Dole\u017eal V. Psychodynamics of LSD hallucinations and their bearing on individual psychotherapy. Activ Nerv Super 1963;7:308\u2013309.","journal-title":"Activ Nerv Super"},{"issue":"2","key":"e_1_3_3_78_1","first-page":"151","article-title":"The use of LSD in psychiatry","volume":"37","author":"MacCallum WAG","year":"1968","unstructured":"77.MacCallum WAG. The use of LSD in psychiatry. Ulster Med J 1968;37(2):151\u2013154.","journal-title":"Ulster Med J"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1960.9916425"},{"key":"e_1_3_3_80_1","first-page":"21","article-title":"Some early observations on the use of psilocybin in psychiatric patients","volume":"2","author":"Clark B","year":"1967","unstructured":"79.Clark B. Some early observations on the use of psilocybin in psychiatric patients. Br J Soc Psychiatry 1967;2:21\u201326.","journal-title":"Br J Soc Psychiatry"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/002076407001600204"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1981.10471888"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195503000-00010"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.106.444.1073"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.107.446.109"},{"key":"e_1_3_3_86_1","first-page":"42","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Davies BM","year":"1963","unstructured":"85.Davies BM. Phencyclidine: its use in psychiatry. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 42\u201347."},{"key":"e_1_3_3_87_1","first-page":"51","volume-title":"Lysergic acid diethylamide and mescaline in experimental psychiatry","author":"Abramson HA","year":"1956","unstructured":"86.Abramson HA. Some observations on normal volunteers and patients. In: Lysergic acid diethylamide and mescaline in experimental psychiatry. (Cholden L., ed.) Grune & Stratton: New York, NY; 1956; pp. 51\u201354."},{"key":"e_1_3_3_88_1","first-page":"114","article-title":"La psilocybine: Perspectives d\u2019utilisation en psychiatrie clinique","volume":"63","author":"Aguilar MT","year":"1963","unstructured":"87.Aguilar MT. La psilocybine: Perspectives d\u2019utilisation en psychiatrie clinique. Acta Neurol Psychiatr Belg 1963;63:114\u2013131.","journal-title":"Acta Neurol Psychiatr Belg"},{"key":"e_1_3_3_89_1","first-page":"191","article-title":"L\u2019impiego della dietilamide dell\u2019acido lisergico nelle psiconevrosi","volume":"8","author":"Giberti F","year":"1956","unstructured":"88.Giberti F, , Gregoretti L, , Boeri G. L\u2019impiego della dietilamide dell\u2019acido lisergico nelle psiconevrosi. Sist Nerv 1956;8:191\u2013208.","journal-title":"Sist Nerv"},{"key":"e_1_3_3_90_1","first-page":"303","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Rolo A","year":"1967","unstructured":"89.Rolo A, , Krinsky LW, , Goldfarb L, et al. Multitherapist interviews utilizing LSD. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA, ed.) Bobbs-Merrill: Indianapolis, IN; 1967; pp. 303\u2013324."},{"key":"e_1_3_3_91_1","first-page":"1470","article-title":"Een behandeling van een suicidale pati\u00ebnt met LSD-25","volume":"113","author":"van Ree F","year":"1969","unstructured":"90.van Ree F. Een behandeling van een suicidale pati\u00ebnt met LSD-25. Ned Tijdschr Geneeskd 1969;113:1470\u20131472.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_3_92_1","first-page":"151","volume-title":"The use of LSD in psychotherapy","author":"van Rhijn CH","year":"1960","unstructured":"91.van Rhijn CH. Symbolysis: Psychotherapy by symbolic presentation. In: The use of LSD in psychotherapy. (Abramson HA., ed.) New York (NY): Josiah Macy Foundation; 1960. pp. 151\u2013198."},{"key":"e_1_3_3_93_1","first-page":"576","volume-title":"Neuro-psychopharmacology","author":"Giberti F","year":"1959","unstructured":"92.Giberti F, , Gregoretti L. Nouveaux aspects des exp\u00e9riences avec des drogues psychotropes (LSD-25 et LAE-32) dans les psychon\u00e9vroses. In: Neuro-psychopharmacology. (Bradley PB, , Deniker P, , Radouco-Thomas C., eds.) Elsevier: Amsterdam; 1959; pp. 576\u2013578."},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.116.533.443"},{"key":"e_1_3_3_95_1","first-page":"52","article-title":"Psychedelics and people as adjuncts to psychotherapy","volume":"2","author":"Eisner BG","year":"1967","unstructured":"94.Eisner BG. Psychedelics and people as adjuncts to psychotherapy. Br J Soc Psychiatry 1967;2:52\u201358.","journal-title":"Br J Soc Psychiatry"},{"key":"e_1_3_3_96_1","first-page":"450","article-title":"The treatment of frigidity with LSD and Ritalin","volume":"1","author":"Ling TM","year":"1964","unstructured":"95.Ling TM, , Buckman J. The treatment of frigidity with LSD and Ritalin. Psychedelic Rev 1964;1:450\u2013458.","journal-title":"Psychedelic Rev"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1955.9916165"},{"issue":"3","key":"e_1_3_3_98_1","first-page":"282","article-title":"Follow-up evaluation of LSD psychotherapy of inpatients","volume":"10","author":"Hausner M","year":"1968","unstructured":"97.Hausner M, , Dole\u017eal V. Follow-up evaluation of LSD psychotherapy of inpatients. Act Nerv Super (Praha) 1968;10(3):282\u2013283.","journal-title":"Act Nerv Super (Praha)"},{"key":"e_1_3_3_99_1","first-page":"33","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Sandison RA","year":"1963","unstructured":"98.Sandison RA. Certainty and uncertainty in the LSD treatment of psychoneurosis. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 33\u201336."},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196001000-00005"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.118.543.229"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1964.tb04951.x"},{"key":"e_1_3_3_103_1","first-page":"223","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Martin JA","year":"1967","unstructured":"102.Martin JA. LSD analysis. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967, pp. 223\u2013236."},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01562041"},{"issue":"8","key":"e_1_3_3_105_1","first-page":"241","article-title":"L.S.D. 25 as an aid in psychotherapy: Preliminary report of a new drug","volume":"11","author":"Busch AK","year":"1950","unstructured":"104.Busch AK, , Johnson WC. L.S.D. 25 as an aid in psychotherapy: Preliminary report of a new drug. Dis Nerv Syst 1950;11(8):241\u2013243.","journal-title":"Dis Nerv Syst"},{"key":"e_1_3_3_106_1","first-page":"94","article-title":"El uso cl\u00ednico de las drogas alucin\u00f3genas","volume":"7","author":"Fontana AE","year":"1961","unstructured":"105.Fontana AE. El uso cl\u00ednico de las drogas alucin\u00f3genas. Acta Neuropsiquiatr Argent 1961;7:94\u201398.","journal-title":"Acta Neuropsiquiatr Argent"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1968.tb01991.x"},{"key":"e_1_3_3_108_1","first-page":"112","volume-title":"Hallucinogenic drugs and their psychotherapeutic use","author":"Martin JA","year":"1963","unstructured":"107.Martin JA. A case of psychopathic personality with homosexuality treated by LSD. In: Hallucinogenic drugs and their psychotherapeutic use. (Crockett R, , Sandison RA, , Walk A., eds.) H.K. Lewis: London; 1963; pp. 112\u2013115."},{"key":"e_1_3_3_109_1","first-page":"380","article-title":"Psychoterapie exhibicionistu pomoc\u00ed lysergamidu Spofa","volume":"9","author":"Taus L","year":"1967","unstructured":"108.Taus L. Psychoterapie exhibicionistu pomoc\u00ed lysergamidu Spofa. Act Nerv Super 1967;9:380\u2013381.","journal-title":"Act Nerv Super"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-195912000-00007"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.100.419.508"},{"key":"e_1_3_3_112_1","first-page":"428","article-title":"\u00c0 propos de l\u2019utilisation des substances dysleptiques en psychoth\u00e9rapie: R\u00e9sultats favorables de s\u00e9ances r\u00e9p\u00e9t\u00e9es","volume":"49","author":"St\u00e9venin L","year":"1960","unstructured":"111.St\u00e9venin L, , Benoit JC. \u00c0 propos de l\u2019utilisation des substances dysleptiques en psychoth\u00e9rapie: R\u00e9sultats favorables de s\u00e9ances r\u00e9p\u00e9t\u00e9es. L\u2019Enc\u00e9phale 1960;49:428\u2013434.","journal-title":"L\u2019Enc\u00e9phale"},{"key":"e_1_3_3_113_1","first-page":"59","article-title":"The effectiveness of psychedelic (LSD) therapy: A preliminary report","volume":"2","author":"Savage CC","year":"1968","unstructured":"112.Savage CC, , Hughes MA, , Mogar R. The effectiveness of psychedelic (LSD) therapy: A preliminary report. Br J Soc Psychiatry 1968;2:59\u201366.","journal-title":"Br J Soc Psychiatry"},{"key":"e_1_3_3_114_1","first-page":"91","volume-title":"Psychopharmacological agents for the terminally ill and bereaved","author":"Grof S","year":"1973","unstructured":"113.Grof S, , Pahnke WN, , Goodman LE, et al. Psychedelic drug-assisted psychotherapy in patients with terminal cancer. Part two. In: Psychopharmacological agents for the terminally ill and bereaved. (Goldberg IK, , Malitz S, , Kutscher AH, ed.) Columbia University Press: New York, NY; 1973, pp. 91\u2013133."},{"key":"e_1_3_3_115_1","first-page":"33","volume-title":"Psychedelic drugs","author":"Pahnke WN","year":"1969","unstructured":"114.Pahnke WN, , Kurland AA, , Goodman LE, et al. LSD-assisted psychotherapy with terminal cancer patients. In: Psychedelic drugs. (Hicks RE, , Fink PJ, ed.) Grune & Stratton: New York, NY; 1969. pp. 33\u201342."},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.2190\/YH2E-R6MC-N8MQ-0TR5"},{"key":"e_1_3_3_117_1","volume-title":"The human encounter with death","author":"Grof S","year":"1978","unstructured":"116.Grof S, , Halifax J. The human encounter with death. Dutton: New York, NY; 1978."},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1985.10524332"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115531"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32070380"},{"key":"e_1_3_3_121_1","first-page":"1373","article-title":"Acci\u00f3n de la dietilamida del \u00e1cido d-lis\u00e9rgico (LSD-25) en las neurosis obsesivas","volume":"117","author":"David JM","year":"1960","unstructured":"120.David JM. Acci\u00f3n de la dietilamida del \u00e1cido d-lis\u00e9rgico (LSD-25) en las neurosis obsesivas. Sem Med 1960;117:1373\u20131384, 1399.","journal-title":"Sem Med"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770907709104184"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00149.x"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1726818"},{"key":"e_1_3_3_125_1","volume-title":"Psilocybin for treatment of obsessive compulsive disorder. ClinicalTrials.gov identifier: NCT03300947","author":"Moreno FA","year":"2024","unstructured":"124.Moreno FA. Psilocybin for treatment of obsessive compulsive disorder. ClinicalTrials.gov identifier: NCT03300947. ClinicalTrials.gov; 2024."},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1110"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2025.152619"},{"key":"e_1_3_3_128_1","first-page":"214","article-title":"Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilocybin)","volume":"89","author":"Heimann H","year":"1962","unstructured":"127.Heimann H. Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilocybin). Schweiz Arch Neurol Neurochir Psychiatr 1962;89:214\u2013220.","journal-title":"Schweiz Arch Neurol Neurochir Psychiatr"},{"key":"e_1_3_3_129_1","volume-title":"Psilocybin in co-occurring major depressive disorder and borderline personality disorder (Clinical Trial No. NCT05399498)","author":"Grant JE","year":"2025","unstructured":"128.Grant JE. Psilocybin in co-occurring major depressive disorder and borderline personality disorder (Clinical Trial No. NCT05399498). ClinicalTrials.gov; 2025."},{"key":"e_1_3_3_130_1","volume-title":"The effects of MDMA (3,4-methylenedioxymethamphetamine) in social cognition in borderline personality disorder (Clinical Trial No. NCT06683014)","author":"Fineberg SK","year":"2026","unstructured":"129.Fineberg SK. The effects of MDMA (3,4-methylenedioxymethamphetamine) in social cognition in borderline personality disorder (Clinical Trial No. NCT06683014). ClinicalTrials.gov; 2026."},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2025.03.022"},{"key":"e_1_3_3_132_1","volume-title":"Social Anxiety MDMA-Assisted Therapy Investigation: a randomized, delayed treatment control Phase 2 study of the safety and effectiveness of manualized MDMA-assisted therapy for the treatment of social anxiety disorder (Clinical Trial No. NCT05138068)","author":"Luoma JB","year":"2025","unstructured":"131.Luoma JB. Social Anxiety MDMA-Assisted Therapy Investigation: a randomized, delayed treatment control Phase 2 study of the safety and effectiveness of manualized MDMA-assisted therapy for the treatment of social anxiety disorder (Clinical Trial No. NCT05138068). ClinicalTrials.gov; 2025."},{"key":"e_1_3_3_133_1","volume-title":"Safety, tolerability, and preliminary efficacy of psilocybin oral solution in adults with generalized anxiety disorder (Clinical Trial No. NCT06969170)","author":"Soares CN","year":"2025","unstructured":"132.Soares CN. Safety, tolerability, and preliminary efficacy of psilocybin oral solution in adults with generalized anxiety disorder (Clinical Trial No. NCT06969170). ClinicalTrials.gov; 2025."},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.12.040"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01567467"},{"key":"e_1_3_3_136_1","volume-title":"Tolerability of MDMA in schizophrenia (Clinical Trial No. NCT05770375)","author":"Bershad A","year":"2025","unstructured":"135.Bershad A. Tolerability of MDMA in schizophrenia (Clinical Trial No. NCT05770375). ClinicalTrials.gov; 2025."},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1159\/000468273"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112439253"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-025-00629-8"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591576005301108"},{"key":"e_1_3_3_141_1","first-page":"48","article-title":"Discussion","volume":"53","author":"Robinson JT","year":"1960","unstructured":"140.Robinson JT. Discussion. Proc R Soc Med 1960;53:48\u201350.","journal-title":"Proc R Soc Med"},{"issue":"3","key":"e_1_3_3_142_1","article-title":"L\u2019exp\u00e9rience lysergique: LSD-25; \u00e0 propos de 75 observations cliniques","volume":"47","author":"Delay J","year":"1958","unstructured":"141.Delay J, , Benda P. L\u2019exp\u00e9rience lysergique: LSD-25; \u00e0 propos de 75 observations cliniques. L\u2019Encephale 1958;47(3)","journal-title":"L\u2019Encephale"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.13481"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300501"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788155"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103149"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.70152"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1505894"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503245251348272"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1963.tb07856.x"},{"key":"e_1_3_3_153_1","first-page":"601","volume-title":"The use of LSD in psychotherapy and alcoholism","author":"Wicks MS","year":"1967","unstructured":"152.Wicks MS. The use of LSD in probation casework. In: The use of LSD in psychotherapy and alcoholism. (Abramson HA., ed.) Bobbs-Merrill: Indianapolis, IN; 1967; pp. 601\u2013615."},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjc.12424"},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2026.116992"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases11040159"},{"key":"e_1_3_3_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073759"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20220088"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1080\/00223980.1956.9916216"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01062110"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109422"}],"container-title":["Psychedelic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/28314425261455416","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/28314425261455416","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/28314425261455416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:46:28Z","timestamp":1784987188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/28314425261455416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":161,"alternative-id":["10.1177\/28314425261455416"],"URL":"https:\/\/doi.org\/10.1177\/28314425261455416","relation":{},"ISSN":["2831-4425","2831-4433"],"issn-type":[{"value":"2831-4425","type":"print"},{"value":"2831-4433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"28314425261455416"}}